2016_Head & Neck COURSE BOOK

BERIL-1 Primary Endpoint: Progression-free Survival

Protocol-specified criteria for success were: HR ≤0.67 and posterior probability of (HR <1) >97.5%

6-month PFS rate: 34% vs 19%

CI, confidence interval. *The 97.5% Bayesian posterior probability criteria is equivalent to a 95% CI being <1; † Nominal p-value, not adjusted for multiple testing.

Soulières D et al. ASCO 2016:Abstract 6008

June 5, 2016